Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C

Technology appraisal guidance
Reference number: TA106
Published: 23 August 2006
Last updated: 27 November 2013

TA106 Hepatitis C - peginterferon alfa and ribavirin: - Appendix A - provisional matrix of stakeholders

TA106 Hepatitis C - peginterferon alfa and ribavirin: - Appendix A - provisional matrix of stakeholders

TA106 Hepatitis C - peginterferon alfa and ribavirin: - Appendix A - provisional matrix of stakeholders
14 October 2013
(100.31 Kb 29 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 09 October 2013